Hemostemix IncHemostemix IncHemostemix Inc

Hemostemix Inc

No trades
See on Supercharts
Market capitalization
‪3.38 M‬USD
−0.0303USD
‪−3.86 M‬USD
‪74.52 M‬
Beta (1Y)
0.20

About Hemostemix Inc

CEO
Thomas A. Smeenk
Headquarters
Calgary
Founded
2006
FIGI
BBG00BNK7PL9
Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HMTXF is 0.0371 USD — it has decreased by 17.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hemostemix Inc stocks are traded under the ticker HMTXF.
Hemostemix Inc is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
HMTXF stock is 21.56% volatile and has beta coefficient of 0.20. Check out the list of the most volatile stocks — is Hemostemix Inc there?
Yes, you can track Hemostemix Inc financials in yearly and quarterly reports right on TradingView.
HMTXF net income for the last quarter is ‪−189.36 K‬ USD, while the quarter before that showed ‪−214.96 K‬ USD of net income which accounts for 11.91% change. Track more Hemostemix Inc financial stats to get the full picture.
Today Hemostemix Inc has the market capitalization of ‪3.38 M‬, it has decreased by 13.59% over the last week.
No, HMTXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HMTXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hemostemix Inc stock right from TradingView charts — choose your broker and connect to your account.
HMTXF reached its all-time high on Jan 7, 2016 with the price of 13.6000 USD, and its all-time low was 0.0371 USD and was reached on Apr 11, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hemostemix Inc technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hemostemix Inc stock shows the sell signal. See more of Hemostemix Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.